-
Monfils falls to Tien in US Open in Grand Slam farewell
-
Toulouse eye Top 14 history after 'difficult' summer
-
Arsenal brace for Chelsea test as Spurs seek spark
-
Springboks and All Blacks seek series lead after war of words
-
Efficient Rybakina reaches US Open third round
-
Bundesliga brings the band back together in Premier League's shadow
-
Taiwan boxer Lin considered 'graceful exit' after Paris Games gold
-
Asian stocks rally as traders pare rate bets ahead of jobs data
-
'I miss my home': Cambodians displaced by conflict start over
-
War-bruised Myanmar finds relief in bareknuckle bloodsport
-
Ailing Auger-Aliassime falls at US Open as Swiatek, Osaka and Gauff advance
-
Gauff downs Badosa to reach US Open third round
-
Tesla launches self-driving 'Cybercab' in Texas
-
New Zealand approves use of party drug MDMA to treat trauma
-
'Wallace & Gromit' creators turn 50 with spook-tacular Shaun yarn
-
Westerners test their mettle at World Nomad Games in Kyrgyzstan
-
New York's Muslims reclaim their city after 9/11 backlash
-
Gauff cruises into US Open third round
-
Premier League transfer windfall a lifeline for ailing French clubs
-
Kyrgios gets month ban for cocaine, enters treatment programme
-
Chile protesters see shades of Pinochet in new security plan
-
Colombian judge bans strikes on guerrillas if minors are present
-
Carreras reverts to fullback as Argentina change four for Australia Test
-
Khachanov shocks ailing Auger-Aliassime, Swiatek and Osaka advance at US Open
-
Wilson back to lead Australia as Kiss rotates team for Argentina
-
Lone juror blocking verdict in US mother's child murder trial: defense
-
Yen surges on new intervention talk, US stocks rally
-
'Kinda chic' - Williams sisters set to launch US Open doubles bid
-
Japan's Ueda fires Lille top of Ligue 1 on debut
-
Volkswagen says cutting 100,000 jobs by end of decade
-
Arsenal chief executive reveals 'dynasty' ambition
-
Russia slaps curfew on charity director over army criticism
-
Spanish PM says no 'solid proof' Morocco planned migrant rush
-
Ailing Auger-Aliassime upset by Khachanov at US Open
-
Iran war is not a war, US VP Vance says
-
Richarlison omitted from Tottenham's Premier League squad
-
Khachanov stuns third-seeded Auger-Aliassime in US Open second round
-
How El Nino is choking the Panama Canal
-
Bordeaux facing sixth-tier football after French federation upholds relegation
-
Hamilton drives his Ferrari dream at Monza
-
Stoic Verstappen looking beyond 'painful' Monza weekend
-
Senegal has an IMF loan, now what?
-
OpenAI begins rollout of new powerful AI model GPT-6 Astra
-
Auger-Aliassime upset by Khachanov at US Open
-
FIFA blasts UEFA 'smear campaign,' fights World Cup plan disclosures
-
Hugging Face, the French start-up that became AI's warehouse
-
Zelensky hopes to host US envoys in Kyiv in 'coming days'
-
World Cup winner Llorente retires from Spain team at 31
-
Martinelli joins Al-Hilal from Arsenal for reported £60 million
-
Osaka squeezes into US Open third round
Chemical hair straighteners may cause uterine cancer: study
Women who frequently use chemical hair straightening products could face more than twice the risk of uterine cancer compared to those who never use them, according to a new study published Monday.
The findings, published in the Journal of the National Cancer Institute, have particular relevance for Black women, who make up a majority of users of straightening products in the United States.
Scientists lauded the work, calling for action even though more work is required to confirm the conclusions, in what is an understudied area of research.
Lead author Alexandra White, a cancer epidemiologist with the National Institutes of Health led the study, told AFP it grew out of her previous research that found a link between permanent hair dye and straighteners and breast and ovarian cancers.
"We know that these straighteners contain many different chemicals, including endocrine disruptors, and we would expect them to have adverse health effects for hormone sensitive cancers," she said.
"That led us to extend our previous work, just focusing on uterine cancer."
Uterine cancer accounts for three percent of all new cancers but is the most common cancer of the female reproductive system, with more than 65,000 new cases and 12,500 deaths are expected in 2022.
The outlook is generally good if the cancer is caught early, but treatment often involves removing the uterus, which would preclude child-bearing.
The new paper relied on data from more than 33,000 US women aged 35-74 who took part in the Sister Study, which is led by the government and designed to identify risk factors for cancer and other conditions.
Over the course of 11 years, 378 women developed uterine cancer, which primarily affects tissue lining the uterus called endometrium. Type 1, the most common form of the cancer, is thought to be linked to having too much of the sex hormone estrogen.
Women who reported using hair straightening products in the past year were almost twice as likely to develop uterine cancer compared to women that never used them, the researchers found.
The link was stronger still for frequent users -- defined as more than four uses in the past 12 months. These women had around 2.5 times the risk of developing the cancer compared to women who never used the products.
No similar associations were found for other hair products including dyes, bleach, highlights, or perms.
- Brazilian blowouts -
"The concern is that there are chemicals in these products that act essentially like estrogen in the body," said White, disrupting normal hormonal processes that could influence cancer risk.
A second possibility is that some products include carcinogens, such as formaldehyde, to break the bonds between keratin proteins in hair, which changes its structure and makes it straight.
Though the study did not specifically ask women what products they used, a particular keratin treatment known as "Brazilian blowouts" was popular at the time the women were enrolled for this study, between 2003 and 2009, though its use has decreased since.
White said one of the strengths of the study was that it asked women about the products years before they actually went on to develop cancer, which limits the possibility of people misremembering or wrongly attribute their exposures.
But a key limitation was they weren't able to collect information on the types of straighteners used or specific brands, which would have further strengthened evidence.
White said more lab work should be done to study the proposed ways the chemicals cause cancer, as well as more population studies that recruit racially diverse populations and capture information on brands.
A related commentary in the journal acknowledged some shortcomings, but said the study added to a "growing body of evidence" that "hair-straightening products are associated with hormone-related cancers in women," and called for evidence-driven policy changes.
It added that the personal care product industry upheld Eurocentric "racialized standards of beauty" and persistently failed to conform to being transparent about chemical constituents and formulations.
F.Cardoso--PC